MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 62 filers reported holding MIRATI THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $15,401,000 | +34.0% | 210,115 | -22.4% | 0.01% | +22.2% |
| Q4 2018 | $11,492,000 | +118.5% | 270,906 | +142.6% | 0.01% | +350.0% |
| Q3 2018 | $5,260,000 | +89.1% | 111,658 | +97.9% | 0.00% | 0.0% |
| Q2 2018 | $2,782,000 | +945.9% | 56,434 | +10.2% | 0.00% | – |
| Q1 2017 | $266,000 | -6.7% | 51,202 | -14.7% | 0.00% | – |
| Q4 2016 | $285,000 | -45.5% | 60,041 | -24.1% | 0.00% | – |
| Q3 2016 | $523,000 | +90.2% | 79,147 | +57.1% | 0.00% | – |
| Q2 2016 | $275,000 | -63.7% | 50,372 | +42.3% | 0.00% | -100.0% |
| Q1 2016 | $757,000 | -32.3% | 35,395 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,118,000 | -0.8% | 35,395 | +8.1% | 0.00% | 0.0% |
| Q3 2015 | $1,127,000 | +6.5% | 32,729 | -2.7% | 0.00% | 0.0% |
| Q2 2015 | $1,058,000 | +32.1% | 33,632 | +23.2% | 0.00% | 0.0% |
| Q1 2015 | $801,000 | +58.3% | 27,309 | 0.0% | 0.00% | – |
| Q4 2014 | $506,000 | +4.5% | 27,309 | -1.2% | 0.00% | – |
| Q3 2014 | $484,000 | -12.5% | 27,630 | 0.0% | 0.00% | – |
| Q2 2014 | $553,000 | – | 27,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
| Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
| Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
| Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
| Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
| Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
| Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
| Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
| Trexquant Investment LP | 42,879 | $223,000 | 0.03% |